{"title":"HIV治疗的优化结构化治疗中断及其可控性绩效分析","authors":"Ji-hyun Ko, Wonhee Kim, C. Chung","doi":"10.1109/CDC.2004.1428828","DOIUrl":null,"url":null,"abstract":"This paper presents dynamic programming therapy to reduce medication and establish long-term immune response against HIV-infection. Understanding HIV-relaled immune system control enables better HIV therapy without using full-treatments. Discrete regimen and continuous regimen characteristics are compared. Controllability of HIV-related immune system is analyzed for better understanding of optimal control in HIV therapy. Using optimal control provides more effective therapy than the full treatment without interruption in terms of controllability analysis. Case studies indicated the proposed therapy induces long-term non-progression while preserving high CD4 T-helper cell count and low virus load in HIV-infected patients.","PeriodicalId":254457,"journal":{"name":"2004 43rd IEEE Conference on Decision and Control (CDC) (IEEE Cat. No.04CH37601)","volume":"75 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2006-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"30","resultStr":"{\"title\":\"Optimized structured treatment interruption for HIV therapy and its performance analysis on controllability\",\"authors\":\"Ji-hyun Ko, Wonhee Kim, C. Chung\",\"doi\":\"10.1109/CDC.2004.1428828\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This paper presents dynamic programming therapy to reduce medication and establish long-term immune response against HIV-infection. Understanding HIV-relaled immune system control enables better HIV therapy without using full-treatments. Discrete regimen and continuous regimen characteristics are compared. Controllability of HIV-related immune system is analyzed for better understanding of optimal control in HIV therapy. Using optimal control provides more effective therapy than the full treatment without interruption in terms of controllability analysis. Case studies indicated the proposed therapy induces long-term non-progression while preserving high CD4 T-helper cell count and low virus load in HIV-infected patients.\",\"PeriodicalId\":254457,\"journal\":{\"name\":\"2004 43rd IEEE Conference on Decision and Control (CDC) (IEEE Cat. No.04CH37601)\",\"volume\":\"75 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2006-02-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"30\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"2004 43rd IEEE Conference on Decision and Control (CDC) (IEEE Cat. No.04CH37601)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1109/CDC.2004.1428828\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"2004 43rd IEEE Conference on Decision and Control (CDC) (IEEE Cat. No.04CH37601)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/CDC.2004.1428828","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Optimized structured treatment interruption for HIV therapy and its performance analysis on controllability
This paper presents dynamic programming therapy to reduce medication and establish long-term immune response against HIV-infection. Understanding HIV-relaled immune system control enables better HIV therapy without using full-treatments. Discrete regimen and continuous regimen characteristics are compared. Controllability of HIV-related immune system is analyzed for better understanding of optimal control in HIV therapy. Using optimal control provides more effective therapy than the full treatment without interruption in terms of controllability analysis. Case studies indicated the proposed therapy induces long-term non-progression while preserving high CD4 T-helper cell count and low virus load in HIV-infected patients.